Pfizer's Strategic Move: Potential $7.3 Billion Acquisition of Metsera Set to Shake Up Weight-Loss Drug Market ...Middle East

Pfizer is on the verge of acquiring Metsera, a breakthrough weight-loss drug developer, in a deal valued at $7.3 billion. The acquisition, as reported by the Financial Times, awaits official confirmation with Pfizer set to pay $47.50 per share in cash.

Hence then, the article about pfizer s strategic move potential 7 3 billion acquisition of metsera set to shake up weight loss drug market was published today ( Monday 22/09/2025 - 07:51 AM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer's Strategic Move: Potential $7.3 Billion Acquisition of Metsera Set to Shake Up Weight-Loss Drug Market )

Also on site :

• Sweden Thwarts Suspected Russian Drone Amid NATO Exercises
• Airborne Revival: New Cheetah Batch Flies from Africa to India
• Voices: ‘The battle lines are drawn’: How readers responded to the Greens’ historic Gorton and Denton by-election win